Bank Of New York Mellon Corp Immuno Gen, Inc. Transaction History

Bank Of New York Mellon Corp

$538 Trillion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$3.67 - $4.92 $2.87 Million - $3.85 Million	782,033 New	782,033 $3 Billion
Q4 2022 Feb 14, 2023	BUY	$4.55 - $6.31 $3.59 Million - $4.98 Million	789,306 New	789,306 $3.91 Million
Q3 2022 Nov 14, 2022	BUY	$4.48 - $6.47 $310,060 - $447,788	69,210 Added 9.27%	816,072 $3.9 Million
Q2 2022 Aug 15, 2022	SELL	$3.15 - $5.76 $163,926 - $299,750	-52,040 Reduced 6.51%	746,862 $3.36 Million
Q1 2022 May 11, 2022	BUY	$4.26 - $7.48 $222,555 - $390,777	52,243 Added 7.0%	798,902 $3.8 Million
Q4 2021 Feb 11, 2022	SELL	$4.75 - $7.5 $46,668 - $73,687	-9,825 Reduced 1.3%	746,659 $5.54 Million
Q3 2021 Nov 12, 2021	BUY	$5.02 - $6.59 $357,298 - $469,043	71,175 Added 10.39%	756,484 $4.29 Million
Q2 2021 Aug 11, 2021	SELL	$5.79 - $8.6 $720,797 - $1.07 Million	-124,490 Reduced 15.37%	685,309 $4.52 Million
Q1 2021 May 13, 2021	SELL	$6.5 - $10.53 $103,532 - $167,721	-15,928 Reduced 1.93%	809,799 $6.56 Million
Q4 2020 Feb 09, 2021	BUY	$3.7 - $7.66 $157,782 - $326,653	42,644 Added 5.45%	825,727 $5.33 Million
Q3 2020 Nov 12, 2020	SELL	$3.45 - $4.89 $8,014 - $11,359	-2,323 Reduced 0.3%	783,083 $2.82 Million
Q2 2020 Aug 12, 2020	BUY	$3.32 - $5.34 $22,655 - $36,440	6,824 Added 0.88%	785,406 $3.61 Million
Q1 2020 May 06, 2020	BUY	$2.12 - $6.8 $114,806 - $368,247	54,154 Added 7.48%	778,582 $2.65 Million
Q4 2019 Feb 14, 2020	BUY	$2.25 - $5.8 $66,741 - $172,045	29,663 Added 4.27%	724,428 $3.7 Million
Q3 2019 Nov 07, 2019	SELL	$2.22 - $3.39 $50,940 - $77,786	-22,946 Reduced 3.2%	694,765 $1.68 Million
Q2 2019 Aug 12, 2019	BUY	$1.8 - $3.3 $172,036 - $315,400	95,576 Added 15.36%	717,711 $1.56 Million
Q1 2019 May 14, 2019	BUY	$2.41 - $5.91 $40,278 - $98,773	16,713 Added 2.76%	622,135 $1.69 Million
Q4 2018 Feb 11, 2019	SELL	$3.94 - $9.7 $35,747 - $88,008	-9,073 Reduced 1.48%	605,422 $2.91 Million
Q3 2018 Nov 09, 2018	BUY	$8.6 - $11.26 $588,300 - $770,262	68,407 Added 12.53%	614,495 $0
Q2 2018 Aug 06, 2018	SELL	$9.52 - $12.15 $424,611 - $541,914	-44,602 Reduced 7.55%	546,088 $5.31 Million
Q1 2018 May 15, 2018	BUY	$6.7 - $12.95 $713,697 - $1.38 Million	106,522 Added 22.0%	590,690 $6.21 Million
Q4 2017 Feb 09, 2018	BUY	$5.07 - $7.92 $2.45 Million - $3.83 Million	484,168	484,168 $3.11 Million

Others Institutions Holding IMGN

# of Institutions

Shares Held

1.41M

Call Options Held

Put Options Held

View Full List

About ImmunoGen, Inc.

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

More about IMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account